Session 1 - 1st Keynote address
Session 5 - Perspectives for therapy
Session 6 - 2nd Keynote address
Session 7 - FMR1 related phenotypes 1
session 8 - FMR1 related phenotypes 2
Session 9 - FXS screening and ethics
Session 10 - Pathogenic consequences of FMR1 mutation
Session 11 - 3rd Keynote address